Hydroxymethylglutaryl coenzyme A inhibitors such as simvastatin, rosuvastatin, and pravastatin are primarily lipid-lowering drugs, but they ameliorate disease severity in colitis models by reducing inflammation and inducing endogenous antioxidants such as SOD and glutathione.82 This evidence concerns the gene SOD1 and colitis.